www.fdanews.com/articles/115273-fda-grants-orphan-drug-designation-for-eur-1073
FDA Grants Orphan Drug Designation for EUR-1073
March 10, 2009
Eurand N.V., a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for EUR-1073 (beclomethasone diproprionate) in pediatric patients.
MSNBC
MSNBC